LWM
BIVV

LBA Wealth Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

LBA Wealth Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$41K Buy
+758
New +$37.3K 0.02% 216

Other funds holding BIVV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LBA Wealth Management's BIVV Position: Q1 2017 in Review

LBA Wealth Management opened a new position in Bioverativ Inc. Common Stock (BIVV) in Q1 2017: 758 shares worth $41K. The stake represents 0.02% of the portfolio and ranks #216 among its holdings.

467 funds tracked by Wall St. Rank hold BIVV as of Q1 2017.

  • LBA Wealth Management held 758 shares of Bioverativ Inc. Common Stock worth $41K as of Q1 2017.
  • Bioverativ Inc. Common Stock was a new LBA Wealth Management position in Q1 2017.
  • Bioverativ Inc. Common Stock made up 0.02% of LBA Wealth Management's portfolio in Q1 2017, its #216 holding.
  • 467 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2017.

Based on LBA Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.